urea has been researched along with Immunoglobulin Light-chain Amyloidosis in 1 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Immunoglobulin Light-chain Amyloidosis: A nonproliferative disorder of the PLASMA CELL characterized by excessive production and misfolding of IMMUNOGLOBULIN LIGHT CHAINS that form insoluble amyloid fibrils (see AMYLOID DEPOSITS) in various tissues. Clinical features include LIVER FAILURE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; RESTRICTIVE CARDIOMYOPATHY, and neuropathies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, EB | 1 |
| Williams, A | 1 |
| Wooliver, C | 1 |
| Heidel, RE | 1 |
| Adams, S | 1 |
| Dunlap, J | 1 |
| Ramirez-Alvarado, M | 1 |
| Blancas-Mejia, LM | 1 |
| Lands, RH | 1 |
| Kennel, SJ | 1 |
| Wall, JS | 1 |
1 other study available for urea and Immunoglobulin Light-chain Amyloidosis
| Article | Year |
|---|---|
Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
Topics: Adult; Aged; Aged, 80 and over; Amyloid; Amyloidogenic Proteins; Amyloidosis; Blotting, Western; Ele | 2017 |